Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20365-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20365-1-AP, RRID:AB_10697660
- Product name
- RbAp46 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RbAp46 antibody (Cat. #20365-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis.
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSK.
CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics.
ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression.
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer.
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.
PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.
RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.
Yang Y, Wang J, Wu Q, Wang Y, Meng H, Zeng L, Qiu T, Zhao H, Hu Q, Weng Q, Liu M, Chen M, Qiu R, Ji J, Chen W
Clinical epigenetics 2026 Jan 17;18(1):29
Clinical epigenetics 2026 Jan 17;18(1):29
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSK.
Qiu R, Chen W, Zhao S, Zhao H, Qiu T, Hu Q, Xu Z, Zeng L, Kong C, Zhang C, Weng Q, Zhao A, Wang J, He Y, Tu J, Chen M, Zhao Z, Yang Y, Ji J
Molecular carcinogenesis 2025 Sep;64(9):1500-1513
Molecular carcinogenesis 2025 Sep;64(9):1500-1513
CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
Chen X, Huang MF, Fan DM, He YH, Zhang WJ, Ding JC, Peng BL, Pan X, Liu Y, Du J, Li Y, Liu ZY, Xie BL, Kuang ZJ, Yi J, Liu W
Nucleic acids research 2024 Jul 8;52(12):6811-6829
Nucleic acids research 2024 Jul 8;52(12):6811-6829
Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics.
Kim M, McDonald EF, Sabusap CMP, Timalsina B, Joshi D, Hong JS, Rab A, Sorscher EJ, Plate L
The Journal of biological chemistry 2023 Oct;299(10):105242
The Journal of biological chemistry 2023 Oct;299(10):105242
ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression.
Li L, Wang X, Hu K, Liu X, Qiu L, Bai C, Cui Y, Wang B, Wang Z, Wang H, Cheng R, Hua J, Hai L, Wang M, Liu M, Song Z, Xiao C, Li B
Oncogene 2023 Jun;42(27):2166-2182
Oncogene 2023 Jun;42(27):2166-2182
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Zhu GQ, Wang Y, Wang B, Liu WR, Dong SS, Chen EB, Cai JL, Wan JL, Du JX, Song LN, Chen SP, Yu L, Zhou ZJ, Wang Z, Zhou J, Shi YH, Fan J, Dai Z
Cellular and molecular gastroenterology and hepatology 2022;13(5):1413-1447
Cellular and molecular gastroenterology and hepatology 2022;13(5):1413-1447
Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer.
He Y, He Z, Zhang X, Liu S
Cancer cell international 2021 Dec 20;21(1):697
Cancer cell international 2021 Dec 20;21(1):697
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.
Wang J, He C, Gao P, Wang S, Lv R, Zhou H, Zhou Q, Zhang K, Sun J, Fan C, Ding G, Lan F
Oncogene 2020 Feb;39(6):1335-1346
Oncogene 2020 Feb;39(6):1335-1346
PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.
Ma C, Guo Y, Zhang Y, Duo A, Jia Y, Liu C, Li B
Biochemical and biophysical research communications 2018 Jun 27;501(3):654-660
Biochemical and biophysical research communications 2018 Jun 27;501(3):654-660
RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.
Yu N, Zhang P, Wang L, He X, Yang S, Lu H
Oncology letters 2018 Dec;16(6):7204-7211
Oncology letters 2018 Dec;16(6):7204-7211
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- A431 cells were subjected to SDS PAGE followed by western blot with 20365-1-AP(RBBP7 antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human cervical cancer using 20365-1-AP(RBBP7 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RbAp46 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human RbAp46. This antibody recognizes human,mouse,rat antigen. The RbAp46 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
